Circulating cell-free DNA is a potential prognostic biomarker of metastatic castration-resistant prostate cancer for taxane therapy
AME Medical Journal(2018)
Abstract
Prostate cancer (PC) is the most frequently diagnosed cancer and a major cause of cancer deaths among men in the developed countries (1). Metastatic prostate cancer remains the major challenge in PC treatment. Despite standard treatment with androgen deprivation therapy (ADT), patients with metastatic PC will inevitably progress to metastatic castration-resistant prostate cancer (mCRPC).
MoreTranslated text
Key words
Metastatic Prostate Cancer,Prostate Cancer
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined